June 18, 2013 7:33 PM ET

Biotechnology

Company Overview of Chemokine Therapeutics Corp.

Company Overview

Chemokine Therapeutics Corp., a development-stage company, focuses on the development of peptide-based drugs for human diseases. The company focuses on the area of chemokines, small proteins that regulate various physiological functions primarily in relation to the immune system. Its drug candidates in human clinical trials include CTCE-9908, which is in phase II clinical trials for the treatment of metastasis and angiogenesis cancers; and CTCE-0214 that is in phase I clinical trials stage for hematological support, and for neutrophil, platelet, and stem cell mobilization. The company’s other products comprise CTCE-0422, which is in preclinical development stage for wound healing; and CTCE-0...

Detailed Description

1727 West Broadway

Suite 400

Vancouver, BC V6J 4S5

Canada

Founded in 1998

6 Employees

Phone:

604-738-6644

Fax:

604-738-6645

www.chemokine.net

Key Executives for Chemokine Therapeutics Corp.

Chief Executive Officer and President
Age: 54
Chief Financial Officer
Age: 66
Assistant Secretary and General Counsel
Director of Investor Relations
Vice President of Corporate Communications
Age: 49
Compensation as of Fiscal Year 2012.

Chemokine Therapeutics Corp. Key Developments

SEC Revokes Registration Of Registered Securities Of Chemokine Therapeutics

An administrative law judge issued an order making findings and revoking registrations by default as to Chemokine Therapeutics Corp. The default order finds that the allegations in the order instituting proceedings are true. The company as issuer of securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (Exchange Act), failed to comply with Exchange Act Section 13(a) and Exchange Act Rules 13a-1 and 13a-13 by failing to file required periodic reports with the Securities and Exchange Commission (SEC). As a result, the administrative law judge ordered the revocation of the registration of each class of company’s registered securities.

SEC Orders Hearings On Registration Suspension Or Revocation Against Chemokine Therapeutics For Failure To Make Required Periodic Filings

In conjunction with this trading suspension, Securities and Exchange Commission (SEC or the Commission) instituted public administrative proceedings to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Chemokine Therapeutics Corp. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company is delinquent in their required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceedings.

Similar Private Companies By Industry

Company Name Region
Scimega Research, Inc. Americas
Glyko Biomedical Ltd. Americas
DNA LandMarks, Inc. Americas
Asmacure Ltée Americas
Performance Genomics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chemokine Therapeutics Corp., please visit www.chemokine.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.